Semorex Technologies

Cancer Therapeutics and IFI/SFI Diagnostics

Health Tech & Life Sciences
Non Active, Jan 2019 ceased to operate
Pre-Funding Jerusalem, Israel Founded 2002
LinkedIn
Last updated 2026-06-18
Total raised
Last: Grant 2015-12
Stage
Pre-Funding
Founded
2002
Headcount
1-10
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Semorex Technologies has discovered molecular compounds that exhibit potent and selective anticancer activity against solid tumors and hematological malignancies. The company is interested in using these compounds, which were found to be nontoxic in mice models, to develop anticancer therapies. Semorex has also developed a diagnostic approach for the rapid and reliable diagnosis of systemic/invasive fungal infection (SFI/IFI). The companys method offers quick and appropriate treatment for patients with fungal infections while ruling out SFI/IFI in individuals suffering from other disease states causing similar symptoms. Semorex Technologies Ltd is an R&D subsidiary of Semorex Inc.

Funding history · 2 rounds · — total

Q&A

What is the primary focus of Semorex Technologies?
Semorex Technologies focuses on developing molecular compounds for anticancer therapies, specifically targeting solid tumors and hematological malignancies. The company also develops diagnostic methods for systemic/invasive fungal infections.
When was Semorex Technologies founded?
Semorex Technologies was founded in March 2002.
What is the current status of Semorex Technologies?
Semorex Technologies is currently inactive, having ceased operations in January 2019.
What is the employee count for Semorex Technologies?
Semorex Technologies has 1-10 employees.
Has Semorex Technologies received any grant funding?
Yes, Semorex Technologies received a grant in March 2015 from the Office of the Chief Scientist, and another grant in December 2015 from Israel's Agency for International Development Cooperation and the Office of the Chief Scientist.
Where is Semorex Technologies headquartered?
Semorex Technologies is headquartered in Jerusalem, Israel.
What is Semorex Technologies' primary sector classification?
Semorex Technologies' primary sector is Health Tech & Life Sciences.
Does Semorex Technologies hold any patents?
Yes, Semorex Technologies holds 1 patent.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & ScreeningDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-technologiesdiagnosticshealthcare-providerspharma-companiesoncologytherapeuticscancerinfectionnanotechnologydrug-delivery
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

LinkedInlinkedin.com/company/8503456

Identifiers & details

Founded2002-3
OfficesFanwood
Status reasonNon Active, Jan 2019 ceased to operate